Bellicum Pharmaceuticals Inc (BLCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 21,837 | 47,657 | 36,996 | 93,816 | 43,695 |
| Marketable Securities | N/A | N/A | N/A | N/A | 49,304 |
| Receivables | N/A | 205 | 2 | 303 | 909 |
| Other current assets | 0 | 0 | 1,643 | 16,851 | 0 |
| TOTAL | $23,801 | $49,131 | $39,443 | $111,854 | $95,295 |
| Non-Current Assets | |||||
| PPE Net | 22 | 12 | 189 | 2,529 | 20,878 |
| Other Non-Current Assets | 0 | 0 | 952 | 1,867 | 5,328 |
| TOTAL | $22 | $12 | $1,141 | $4,396 | $26,206 |
| Total Assets | $23,823 | $49,143 | $40,584 | $116,250 | $121,501 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 11,000 | N/A |
| Accounts payable and accrued liabilities | 486 | 90 | 891 | 2,643 | 3,774 |
| Accrued Expenses | 2,477 | 3,849 | 4,165 | 9,770 | 8,589 |
| Other current liabilities | 809 | 2,773 | 18,820 | 70,551 | 418 |
| TOTAL | $3,772 | $6,712 | $24,701 | $94,418 | $15,804 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 25,717 | 35,832 |
| Deferred Revenues | N/A | N/A | N/A | N/A | 2,983 |
| Other Non-Current Liabilities | 0 | 0 | 344 | 864 | 1,296 |
| TOTAL | $N/A | $N/A | $344 | $26,581 | $37,219 |
| Total Liabilities | $3,772 | $6,712 | $25,045 | $120,999 | $53,023 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 9,046 | 8,552 | 8,318 | 5,048 | 4,432 |
| Common Shares | 87 | 85 | 84 | 507 | 442 |
| Retained earnings | -575,425 | -550,452 | -540,747 | -533,025 | -420,548 |
| Other shareholders' equity | 17,626 | 17,642 | 17,641 | 21,085 | -200 |
| TOTAL | $20,051 | $42,431 | $15,539 | $-4,749 | $68,478 |
| Total Liabilities And Equity | $23,823 | $49,143 | $40,584 | $116,250 | $121,501 |